Atlas Trials

Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.

Clinical trial NCT04251156 · COMPLETED

Trial details

NCT number
NCT04251156
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
OverweightObesityDiabetes Mellitus, Type 2
Start date
2020-12-08
Primary completion
2022-08-23
Enrollment
375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.